| Literature DB >> 35852324 |
Xiaoxiao Zhang1, Mingxiang Ma1, Yumeng Cheng1, Yiqin Huang1, Yuxiao Tan1, Yunqiao Yang1, Yajing Qian1, Xin Zhong1, Yujie Lu1, Hongbin Si1.
Abstract
In this study, we aimed to investigate the occurrence and molecular characteristics of fosfomycin-resistant Enterobacteriaceae isolates from pig, chicken and pigeon farms in Guangxi Province of China. A total of 200 fosfomycin-resistant strains were obtained from food animals and their surrounding environments, with the fosA, fosA3, and fosA7.5 genes being detected in 26% (52/200), 10% (20/200), and 5% (10/200), respectively. Surprisingly, three fosA7.5-producing E. coli isolates were found to be concomitant with fosA3. Most of the fosA-like-gene-positive isolates were multidrug-resistant strains and consistently possessed blaCTX-M-1/CTX-M-9, floR, and blaTEM genes. Only fosA3 was successfully transferred to the recipient strains, and the 29 fosA3-carrying transconjugants exhibited high-level resistance to fosfomycin (MIC ≥ 512 μg/mL). Multilocus sequence typing (MLST) combined with enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) analyses indicated that fosA3 or fosA7.5 genes were spread by horizontal transfer as well as via clonal transmission between E. coli. We used the PCR mapping method to explore the genetic contexts of fosA-like genes, and two representative strains (fEc.1 and fEcg99-1) were fully sequenced. Six different genetic structures surrounding fosA3 were detected and one infrequent context was discovered among the conjugable fosA3-positive E. coli isolates. The five genetic environments of fosA were identified and found to be highly similar to the partial sequence of transposon Tn2921. Furthermore, whole-genome sequencing (WGS) results showed that fosA7.5 was colocalized with mcr-3, blaCMY-63, sul3, tet(A), dfrA, and a number of virulence-related factors on the same chromosomes of strains, and various insertion sequences (IS3/ISL3) were detected upstream or downstream of fosA7.5. The phylogenetic analysis revealed that both fosA7.5- and fosA3-carrying E. coli ST602 and fosA7.5-carrying E. coli ST2599 were closely related to E. coli isolates from humans, which may indicate that they pose a threat to human health. IMPORTANCE Here, we report the widespread and complex genetic environments of fosA-like genes in animal-derived strains in China. The fosA7.5 gene was identified in this study and was found to confer resistance to fosfomycin. The high prevalence of fosA-like genes in farms indicates that food animals serve as a potential reservoir for the resistance genes. This study also discovered that fosfomycin resistance genes were always associated with mobile elements, which would accelerate the transmission of fosA-like genes in strains. Importantly, E. coli ST602 and ST2599 carrying fosA3 or fosA7.5 from food animals had high similarity to E. coli isolates from humans, suggesting that fosA-like genes can be transmitted to humans through the food chain, thus posing a serious threat to public health. Therefore, the prevalence of fosA-like genes isolated from animals should be further monitored.Entities:
Keywords: Enterobacteriaceae; farms; food animals; fosA-like genes; fosfomycin; fosfomycin resistance; genetic environments; transmission
Mesh:
Substances:
Year: 2022 PMID: 35852324 PMCID: PMC9431306 DOI: 10.1128/spectrum.00545-22
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
Characterization of 29 conjugable fosA3-positive E. coli isolates
| Strains | Context of | Resistance profile | Resistance genes |
|---|---|---|---|
| EC27 | V | FFC, CHL, TET, CIP, FOS | |
| EC28 | V | FFC, CHL, TET, CIP, FOS | |
| EC29 | I | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC30 | I | CAZ, FFC, CHL, TET, TGC, FOS | |
| EC31 | II | CAZ, FFC, CHL, TET, FOS | |
| EC32 | II | CAZ, FFC, CHL, TET, CIP, AMK, COL, FOS | |
| EC33 | IV | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC34 | V | FFC, CHL, TET, CIP, FOS | |
| EC35 | VI | FFC, CHL, TET, CIP, FOS | |
| EC36 | VI | CAZ, FFC, CHL, TET, CIP, AMK, FOS | |
| EC37 | I | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC38 | VI | FFC, TET, FOS | |
| EC39 | II | FFC, CHL, TET, CIP, TGC, FOS | |
| EC40 | IV | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC41 | VI | CAZ, FFC, CHL, TET, CIP, TGC, FOS | |
| EC42 | V | FFC, CHL, TET, CIP, FOS | |
| EC43 | IV | CAZ, FFC, CHL, TET, CIP, COL, FOS | |
| EC44 | II | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC45 | I | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC46 | VI | CAZ, FFC, CHL, TET, CIP, TGC, FOS | |
| EC47 | II | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC48 | II | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC49 | VI | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC50 | V | FFC, CHL, TET, CIP, FOS | |
| EC51 | VI | FFC, CHL, TET, CIP, TGC FOS | |
| EC52 | I | FFC, CHL, TET, AMK, TGC, FOS | |
| Kpg84 | / | CAZ, FFC, CHL, TET, CIP, FOS | |
| fEc.1 | III | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg85 | / | CAZ, FFC, CHL, TET, CIP, FOS |
/, the genetic environment of fosA3 was not detected.
CAZ, ceftazidime; FFC, florfenicol; CHL, chloramphenicol; TET, tetracycline; CIP, ciprofloxacin; AMK, amikacin; COL, colistin; TGC, tigecycline; MEM, meropenem; FOS, fosfomycin.
FIG 1ERIC-PCR profiles of 52 fosA3-positive E. coli isolates.
Characterization of 10 fosA7.5-positive isolates and 20 fosA-positive isolates
| Strain | Resistance profile | Resistance gene(s) |
|---|---|---|
| Kpg84 | CAZ, FFC, CHL, TET, CIP, FOS | |
| fEc.1 | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg85 | CAZ, FFC, CHL, TET, CIP, FOS | |
| fEcg991 | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg29 | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg931 | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg932 | CAZ, FFC, CHL, TET, CIP, FOS | |
| ECg91 | CAZ, FFC, CHL, TET, CIP, AMK, FOS | |
| ECg933 | CAZ, FFC, CHL, TET, CIP, FOS | |
| EC315 | FFC, FOS | |
| 20E.1 | FFC, FOS, TET |
|
| 20E.2 | FFC, TGC, FOS, TET |
|
| EC2088 | FFC, CHL, TET, TGC, FOS | |
| 20E.4 | FFC, CHL, TET, TGC, FOS | |
| 20E.5 | FFC, TET, TGC, FOS | |
| 20E.6 | FFC, COL, TGC, FOS |
|
| 20E.7 | TET, COL, TGC, FOS |
|
| 20E.8 | TET, COL, TGC, FOS |
|
| 20E.9 | FFC, TET, COL, TGC, FOS | |
| EC2098 | FFC, CHL, TET, CIP, FOS | |
| 20E.11 | FFC, CHL, TET, FOS |
|
| KP20117 | FFC, CHL, TET, COL, TGC, FOS |
|
| 20E.13 | CAZ, FFC, CHL, TET, CIP, COL, TGC, FOS | |
| 20E.14 | CAZ, FFC, CHL, TET, CIP, COL, TGC, FOS | |
| 20E.15 | CAZ, FFC, CHL, TET, CIP, AMK, FOS | |
| 20E.16 | CAZ, TET, CIP, COL, FOS |
|
| 20E.17 | CAZ, FFC, CHL, TET, COL, TGC, FOS | |
| 20E.18 | CAZ, TET, MEM, FOS | |
| EC1928 | FFC, CHL, TET, CIP, TGC, FOS |
|
| 20E.20 | FFC, COL, TGC, FOS |
|
CAZ, ceftazidime; FFC, florfenicol; CHL, chloramphenicol; TET, tetracycline; CIP, ciprofloxacin; AMK, amikacin; COL, colistin; TGC, tigecycline; MEM, meropenem; FOS, fosfomycin.
FIG 2Analysis of the susceptibility results of 82 Enterobacteriaceae isolates with fosfomycin resistance for 13 antibiotics. (A and B) Drug resistance spectrum; (C) drug resistance proportion; (D) numbers of isolates with given numbers of antimicrobial categories in the resistance phenotypes.
MICs of 10 antimicrobial agents for the 29 fosA3 transconjugants
| Strain | MIC (μg/mL) of | |||||||
|---|---|---|---|---|---|---|---|---|
| CAZ | FFC | CHL | TET | CIP | AMK | RIF | FOS | |
| EC27-T | <1 | 128 | 32 | 2 | <1 | <1 | >1,000 | >512 |
| EC28-T | <1 | 256 | 128 | 64 | <1 | 2 | >1,000 | >512 |
| EC29-T | 8 | 2 | 2 | 2 | <1 | <1 | >1,000 | >512 |
| EC30-T | 16 | 512 | 128 | 128 | <1 | 2 | >1,000 | >512 |
| EC31-T | 4 | 256 | 64 | 32 | <1 | <1 | >1,000 | >512 |
| EC32-T | 16 | 4 | 2 | 2 | <1 | 2 | >1,000 | >512 |
| EC33-T | 8 | 256 | 256 | 32 | <1 | <1 | 125 | >512 |
| EC34-T | <1 | 128 | 64 | 64 | <1 | <1 | >1,000 | >512 |
| EC35-T | <1 | 256 | 128 | 128 | 8 | 2 | >1,000 | >512 |
| EC36-T | 8 | 256 | 64 | 64 | <1 | <1 | >1,000 | >512 |
| EC37-T | 16 | 512 | 128 | 256 | <1 | <1 | >1,000 | >512 |
| EC38-T | <1 | 512 | 256 | 256 | <1 | <1 | >1,000 | >512 |
| EC39-T | 8 | 512 | 256 | 128 | 512 | <1 | 1,000 | >512 |
| EC40-T | 16 | 512 | 256 | 256 | 128 | 2 | >1,000 | >512 |
| EC41-T | 8 | 256 | 64 | 128 | <1 | 2 | >1,000 | >512 |
| EC42-T | <1 | 128 | 64 | 32 | <1 | 2 | >1,000 | >512 |
| EC43-T | 16 | 2 | 2 | 2 | <1 | <1 | >1,000 | >512 |
| EC44-T | 8 | 4 | 2 | 64 | <1 | <1 | >1,000 | >512 |
| EC45-T | 8 | 256 | 128 | 16 | <1 | <1 | >1,000 | >512 |
| EC46-T | 8 | 256 | 64 | 512 | 64 | 2 | >1,000 | >512 |
| EC47-T | <1 | 8 | 64 | 4 | <1 | 8 | >1,000 | >512 |
| EC48-T | <1 | 8 | 64 | 4 | <1 | 16 | >1,000 | >512 |
| EC49-T | 16 | 512 | 256 | 256 | <1 | <1 | >1,000 | >512 |
| EC50-T | <1 | 128 | 64 | 64 | <1 | <1 | >1,000 | >512 |
| EC51-T | <1 | 256 | 128 | 64 | <1 | <1 | >1,000 | >512 |
| EC52-T | 8 | 128 | 128 | 64 | 2 | 8 | >1,000 | >512 |
| fEc.1-T | 8 | 256 | 128 | 2 | <1 | <1 | >1,000 | >512 |
| Kpg84-T | 8 | 256 | 64 | <1 | <1 | <1 | >1,000 | >512 |
| ECg85-T | 8 | 256 | 128 | 2 | <1 | <1 | >1,000 | >512 |
| C600 | <1 | <1 | 2 | 2 | <1 | <1 | >1,000 | <1 |
CAZ, ceftazidime; FFC, florfenicol; CHL, chloramphenicol; TET, tetracycline; CIP, ciprofloxacin; AMK, amikacin; RIF, rifampicin; FOS, fosfomycin.
Plasmid replicons of the 29 fosA3-positive E. coli and their transconjugants
| Strain | Plasmid types | Transconjugant | Plasmid type(s) |
|---|---|---|---|
| EC27 | HI2, FIB, FII, K | EC27-T | FIB, FII |
| EC28 | FIB, FII, K | EC28-T | FIB, FII |
| EC29 | I1, FIA, FIB, FII, K | EC29-T | I1, FIB, FII |
| EC30 | I1, FIB, FII, K | EC30-T | FIB, FII |
| EC31 | FIB, FII, K | EC31-T | FIB, FII |
| EC32 | HI1, HI2, N, FIB, FII | EC32-T | N, FIB, FII |
| EC33 | HI1, FIB, FII, K | EC33-T | FIB, FII |
| EC34 | FIB, FII, K | EC34-T | FIB, FII |
| EC35 | FIB, FII | EC35-T | FIB, FII |
| EC36 | N, FIB, B, FII, K | EC36-T | N, FIB, FII |
| EC37 | FIB, FII, K | EC37-T | FIB, FII |
| EC38 | HI1, FIB, FII | EC38-T | FIB, FII |
| EC39 | FIB, FII, K | EC39-T | FIB, FII |
| EC40 | FIB, FII, K | EC40-T | FIB, FII |
| EC41 | FIB, FII, K | EC41-T | FIB, FII |
| EC42 | HI2, FIB, FII, K | EC42-T | FIB, FII |
| EC43 | HI1, HI2, N, FIB, FII | EC43-T | N, FIB, FII |
| EC44 | FIB, FII, K | EC44-T | FIB, FII |
| EC45 | HI1, FIB, FII, K | EC45-T | FIB, FII |
| EC46 | FIB, FII, K | EC46-T | FIB, FII |
| EC47 | I1, N, FIB, B, FII, K | EC47-T | FIB |
| EC48 | I1, N, FIB, B, FII, K | EC48-T | FIB |
| EC49 | FIB, FII, K | EC49-T | FIB, FII |
| EC50 | FIB, FII, K | EC50-T | FIB, FII |
| EC51 | FIB, FII, K | EC51-T | FIB, FII |
| EC52 | I1, FIB, FII, K | EC52-T | FIB, FII |
| Kpg84 | FrepB, FIB, FII, I1, K | Kpg84-T | I1, FIB, FII |
| fEc.1 | FrepB, FIB, FII, I1, K | Ecg87-T | I1, FIB, FII |
| ECg85 | FrepB, FIB, I1, FII, K | Kpg85-T | I1, FIB, FII |
| fEcg99-1 | FrepB, FIB, I1, Y, FII, K | None | None |
The ST types and of conjugable fosA3-positive E. coli and fosA7.5-carrying isolates
| No. of allele genes | ST | Strain(s) | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| 6 | 6 | 33 | 26 | 11 | 8 | 2 | 1196 | EC27, EC42 |
| 6 | 4 | 14 | 16 | 24 | 8 | 14 | 115 | EC28, EC34, EC35, EC44, EC50 |
| 112 | 11 | 5 | 12 | 8 | 8 | 6 | 7069 | EC37, EC41, EC49 |
| 6 | 11 | 4 | 8 | 8 | 8 | 2 | 48 | EC52 |
| 43 | 41 | 15 | 18 | 11 | 7 | 44 | 5229 | EC29 |
| 20 | 45 | 41 | 43 | 5 | 32 | 2 | 117 | EC32, EC38, EC43 |
| 6 | 4 | 12 | 1 | 20 | 13 | 7 | 23 | EC47, EC48 |
| 6 | 4 | 127 | 16 | 24 | 8 | 6 | 683 | EC30 |
| 6 | 4 | 12 | 1 | 20 | 18 | 7 | 410 | EC36 |
| 6 | 4 | 33 | 16 | 11 | 8 | 6 | 224 | EC33 |
| 6 | 95 | 3 | 18 | 11 | 7 | 14 | 1148 | EC45 |
| 6 | 29 | 32 | 16 | 11 | 8 | 44 | 156 | EC40, EC46, EC39, EC51 |
| 64 | 11 | 5 | 8 | 5 | 8 | 2 | 202 | EC31 |
| 6 | 19 | 33 | 26 | 11 | 8 | 6 | 602 | fEC.1 |
| 6 | 6 | 153 | 26 | 11 | 8 | 6 | 1468 | ECg85 |
| 267 | 6 | 5 | 26 | 9 | 13 | 98 | 2599 | fEcg99-1, ECg931, ECg933, ECg932, ECg91, ECg29 |
| 6 | 19 | 33 | 26 | 11 | 8 | 98 | NA | Kpg84 |
| 653 | 19 | 270 | 26 | 11 | 8 | 7 | 7051 | EC315 |
NA, no ST type of the strain has been obtained.
FIG 3ERIC-PCR profiles of 10 fosA7.5-positive E. coli isolates.
FIG 4Genetic contexts of fosA in E. cloacae and E. hormaechei. orf1, orf2, orf3, orf4, and orf5 encode part of the tryptophan tRNA synthetase, LacI family transcriptional regulator, glycosyl hydrolase family 2, MFS sugar transporter, and a restriction endonuclease. Shaded boxes between sequences indicate homologous regions (>90% sequence identity).
FIG 5Genetic context of fosA3 in E. coli. Arrows indicate the directions of transcription of the genes, and different genes are shown in different colors. Shaded boxes between sequences indicate homologous regions (>90% sequence identity). orf1, orf2, and orf3 encode a hypothetical protein, a CadC-like protein, and a truncated TetR family transcriptional regulator.
FIG 6Comparative genomics analysis of IncFII plasmids carrying fosA3, the external ring represents the annotation of pfEC.1-3.
FIG 7Comparison of the genetic environment of fosA3 in pfEc.1-3 and other closely related IncFII plasmids.
FIG 8Phylogenetic relationship of ST602 E. coli isolate fEC.1 (in red) from this study with ST602 isolates from China and other countries. Blue and gray squares indicate the presence and absence of antimicrobial resistance genes, respectively.
FIG 9Genetic context of fosA7.5 in E. coli. Arrows indicate the directions of transcription of the genes, and different genes are shown in different colors. Shaded boxes between sequences indicate homologous regions (>90% sequence identity). The letter Δ indicates a truncated gene.
FIG 10Phylogenetic relationship of ST2599 E. coli isolate fECg99-1 from this study with isolates from China and other countries. Blue and gray squares indicate the presence and absence of antimicrobial resistance genes, respectively.
MICs for constructed and original strains
| Antibiotic | MIC (μg/mL) for fEC.1 | ||
|---|---|---|---|
| Alone | With pET-28a(+)- | With pET-28a(+)-Top10 | |
| Ceftazidime | 32 | <1 | <1 |
| Florfenicol | 512 | 4 | 2 |
| Chloramphenicol | 256 | 2 | 2 |
| Tetracycline | 32 | 8 | 4 |
| Ciprofloxacin | 128 | <1 | <1 |
| Amikacin | <1 | <1 | <1 |
| Colistin | <1 | <1 | <1 |
| Tigecycline | <0.25 | <0.25 | <0.25 |
| Meropenem | <1 | <1 | <1 |
| Ampicillin | >512 | 256 | 32 |
| Fosfomycin | >512 | >128 | 2 |